PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.

PURPOSE: To improve the risk stratification of patients with rhabdomyosarcoma (RMS) through the use of clinical and molecular biologic data. PATIENTS AND METHODS: Two independent data sets of gene-expression profiling for 124 and 101 patients with RMS were used to derive prognostic gene signatures by using a meta-analysis. These and a previously published metagene signature were evaluated by using cross validation analyses. A combined clinical and molecular risk-stratification scheme that incorporated the PAX3/FOXO1 fusion gene status was derived from 287 patients with RMS and evaluated. RESULTS: We showed that our prognostic gene-expression signature and the one previously published performed well with reproducible and significant effects. However, their effect was reduced when cross validated or tested in independent data and did not add new prognostic information over the fusion gene status, which is simpler to assay. Among nonmetastatic patients, patients who were PAX3/FOXO1 positive had a significantly poorer outcome compared with both alveolar-negative and PAX7/FOXO1-positive patients. Furthermore, a new clinicomolecular risk score that incorporated fusion gene status (negative and PAX3/FOXO1 and PAX7/FOXO1 positive), Intergroup Rhabdomyosarcoma Study TNM stage, and age showed a significant increase in performance over the current risk-stratification scheme. CONCLUSION: Gene signatures can improve current stratification of patients with RMS but will require complex assays to be developed and extensive validation before clinical application. A significant majority of their prognostic value was encapsulated by the fusion gene status. A continuous risk score derived from the combination of clinical parameters with the presence or absence of PAX3/FOXO1 represents a robust approach to improving current risk-adapted therapy for RMS.

De la stratification sociale à la mobilité : une analyse du positionnement professionnel perçu

Avant-propos : De nombreuses études ont été réalisées sur les inégalités factuelles des structures sociales, comprenant aussi bien l'aspect statique de la stratification sociale que l'aspect dynamique de la mobilité sociale (voir par exemple Levy et Suter, 2002, Lemel, 1991, Erikson et Goldthorpe, 1992, Esping-Andersen, 1993). Par contre, les recherches portant sur la perception, par les acteurs, des inégalités des structures sociales sont en comparaison peu nombreuses en ce qui concerne les représentations de la stratification sociale (Levy et al., 1997, Lorenzi-Cioldi et Joye, 1988, Coxon, Davies et Jones, 1986, Zwicky, 1989) et presque inexistantes dans le cas des représentations de la mobilité sociale (Attias-Donfut et Wolff, 2001). La présente recherche se propose d'étudier simultanément la perception de la stratification sociale et de la mobilité sociale intragénérationnelle par les acteurs en intégrant le caractère multidimensionnel du système d'inégalités. Elle défend la thèse fondamentale d'une double origine des inégalités perçues, qui participeraient à la fois d'aspects macrosociaux et mésosociaux de la stratification sociale, les premiers portant sur la structure sociale dans son ensemble, les seconds sur une partie seulement de celle-ci (voir par exemple Kelley et Evans, 1995, Levy, 2002). Dans une perspective systémique, on se trouverait, à côté de la structure macrosociale, en présence de sous-systèmes mésosociaux, de portée restreinte. La perception de la stratification sociale dépendrait alors du cadre de référence adopté par les acteurs, selon qu'il porte sur le système dans son ensemble ou sur un sous-système. Un des objectifs de cette recherche sera d'établir que la pertinence des cadres de référence macrosocial et mésosocial est étroitement liée à la lecture statique ou dynamique de la stratification sociale. Dans le cas statique, celui du positionnement, les représentations sociales s'articuleraient autour des inégalités macrosociales, tenant compte du système dans son ensemble, tandis que dans le cas dynamique, celui de la mobilité ou de l'évolution du positionnement, les inégalités mésosociales, propres aux sous-systèmes, l'emporteraient. D'une part, la perception du positionnement social dépendrait de l'insertion de l'acteur dans la structure sociale, comprise dans son ensemble, et reproduirait les inégalités factuelles macrosociales, telles qu'elles apparaissent par exemple au travers des catégories socioprofessionnelles. D'autre part, la perception du parcours de mobilité ? conservation, amélioration ou dégradation de la position perçue ? resterait indépendante des changements macrosociaux de l'insertion, mais relèverait avant tout de déterminants propres à l'environnement social immédiat de l'acteur. L'environnement de l'acteur, en tant qu'il s'inscrit dans une partie restreinte de la structure sociale, permettrait de saisir les inégalités mésosociales. L'expérience, par les acteurs, de ces deux aspects de la structure sociale conduirait à la mise en place de deux types d'inégalités perçues irréductibles les unes aux autres dans la mesure où le système macrosocial et les sous-systèmes mésosociaux présentent une certaine autonomie. Cette autonomie peut être vue d'une part en rapport avec l'importance propre des organisations de nature mésosociale - en particulier les entreprises - dans les sociétés contemporaines (Sainsaulieu et Segrestin, 1986, Perrow, 1991), d'autre part en relation avec l'hétérogénéité que ces dernières induisent en termes de segmentation du marché de l'emploi (Baron et Bielby, 1980). Dans une large mesure, les organisations intermédiaires se distinguent ainsi de la structure sociale prise dans son ensemble: plutôt que de reproduire les inégalités macrosociales, elles constitueraient des systèmes d'inégalités indépendants, notamment quant à la régulation des parcours professionnels (Bertaux, 1977). Ainsi, la perception de la structure sociale ne se réduirait pas aux seuls facteurs macrosociaux, mais dépendrait, en l'absence d'un modèle d'organisation mésosocial unique, de la diversité des structures intermédiaires. On peut d'ailleurs supposer que la prise en compte des organisations mésosociales est susceptible de pallier la faiblesse des explications classiques en termes macrosociologiques, relevées par les tenants des thèses avançant le déclin du pouvoir structurant de la stratification sociale ou du travail (voir Levy, 2002 et, sur les thèses citées, par exemple Beck, 1983, Matthes, 1983, Berger et Hradil, 1990, Clark et Lipset, 1991). En effet, dans la mesure où l'acteur serait plus souvent confronté aux structures de son environnement social immédiat plutôt qu'à la structure sociale dans son ensemble, la perception pourrait dépendre en premier lieu de facteurs mésosociaux, susceptibles de supplanter ou, à tout le moins, d'atténuer l'effet des facteurs macrosociaux. Une telle approche permet de conserver une lecture structurelle de la perception du positionnement en enrichissant la relation classique entre structure macrosociale et acteur d'une composante mésosociologique, évitant ainsi le recours à une explication culturelle ad hoc Dès lors, la principale question de recherche s'adresse au lien entre structure sociale factuelle et structure sociale perçue. Dans la perspective statique du positionnement, l'effet des structures mésosociales serait tel qu'il se superposerait à la détermination macrosociale de la perception, sans pour autant subvertir la hiérarchie des positions induites par les catégories socioprofessionnelles. Dans la perspective dynamique, en revanche, les changements liés à l'insertion mésosociale peuvent l'emporter sur l'immobilité ou la mobilité définies en termes macrosociologiques. D'une part, en supposant que les plans mésosocial et macrosocial agissent de manière plus ou moins autonome sur la perception, l'amélioration, la conservation ou la dégradation de la position ne coïncide pas nécessairement selon ces deux plans. D'autre part, l'ampleur de la mobilité perçue due à l'écart entre le positionnement mésosocial passé et actuel peut dépasser celle qui est liée à la mobilité macrosociale, surtout si cette dernière est de faible distance. Le passage de la perspective statique à la perspective dynamique peut dès lors être vu comme un moyen de faire apparaître le rôle fondamental joué par les structures mésosociales au sein de la stratification sociale. L'orientation de la recherche consistera d'abord à mettre en évidence, par-delà les différences macrosociales des représentations des positions professionnelles, les variations de la perception au sein des catégories socioprofessionnelles. Ces étapes montreront, à différents égards, que les représentations se singularisent en relation avec l'insertion mésosociale de l'acteur. On verra également que la perception de la mobilité échappe à une détermination macrosociale, mais qu'elle présente une cohérence mésosociale certaine. Ces résultats, insistant sur la prise en compte des structures mésosociales, nous amèneront enfin à un examen systématique des déterminants de la perception du positionnement et du parcours de mobilité, mettant en oeuvre une variété de facteurs explicatifs dépassant un cadre d'analyse purement structurel. La recherche débute par une discussion de la place qui revient à une étude des représentations du parcours professionnel dans le champ des travaux sur la stratification et la mobilité sociale, en particulier sa justification théorique et empirique, et la formulation des hypothèses de recherche (chapitre 1). Elle se poursuit par la présentation de l'échantillonnage et des variables utilisées (chapitre 2). Le traitement des hypothèses de recherche fait l'objet de trois chapitres distincts. Chaque hypothèse s'accompagne, en plus des développements liés à son examen, d'une introduction et d'une conclusion spécifiques. Le premier (chapitre 3) porte sur la perception de la stratification sociale des positions professionnelles, le second (chapitre 4) sur la perception du parcours de mobilité et le troisième (chapitre 5) sur les déterminants sociologiques de la perception des inégalités liées au positionnement et à la mobilité professionnels. Enfin, au traitement des hypothèses fait suite la conclusion de la recherche (chapitre 6).

A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder.

BACKGROUND: Obesity is strongly associated with major depressive disorder (MDD) and various other diseases. Genome-wide association studies have identified multiple risk loci robustly associated with body mass index (BMI). In this study, we aimed to investigate whether a genetic risk score (GRS) combining multiple BMI risk loci might have utility in prediction of obesity in patients with MDD. METHODS: Linear and logistic regression models were conducted to predict BMI and obesity, respectively, in three independent large case-control studies of major depression (Radiant, GSK-Munich, PsyCoLaus). The analyses were first performed in the whole sample and then separately in depressed cases and controls. An unweighted GRS was calculated by summation of the number of risk alleles. A weighted GRS was calculated as the sum of risk alleles at each locus multiplied by their effect sizes. Receiver operating characteristic (ROC) analysis was used to compare the discriminatory ability of predictors of obesity. RESULTS: In the discovery phase, a total of 2,521 participants (1,895 depressed patients and 626 controls) were included from the Radiant study. Both unweighted and weighted GRS were highly associated with BMI (P <0.001) but explained only a modest amount of variance. Adding 'traditional' risk factors to GRS significantly improved the predictive ability with the area under the curve (AUC) in the ROC analysis, increasing from 0.58 to 0.66 (95% CI, 0.62-0.68; χ(2) = 27.68; P <0.0001). Although there was no formal evidence of interaction between depression status and GRS, there was further improvement in AUC in the ROC analysis when depression status was added to the model (AUC = 0.71; 95% CI, 0.68-0.73; χ(2) = 28.64; P <0.0001). We further found that the GRS accounted for more variance of BMI in depressed patients than in healthy controls. Again, GRS discriminated obesity better in depressed patients compared to healthy controls. We later replicated these analyses in two independent samples (GSK-Munich and PsyCoLaus) and found similar results. CONCLUSIONS: A GRS proved to be a highly significant predictor of obesity in people with MDD but accounted for only modest amount of variance. Nevertheless, as more risk loci are identified, combining a GRS approach with information on non-genetic risk factors could become a useful strategy in identifying MDD patients at higher risk of developing obesity.

Efecto de la amputación de antenas en machos y hembras, de la presencia de planta y de la concentración de feromona en el apareamiento de Sesamia nonagrioides Lef.

Se ha estudiado en laboratorio algunos de los factores que pueden influir en el apareamiento de los individuos de Sesamia nonagrioides Let'., como son la presencia de antenas en los individuos de ambos sexos, la presencia de plantas de maíz y la concentración de feromona sintética en el ambiente. Se ha visto que la amputación de antenas a las hembras no tiene ningún efecto sobre el porcentaje de apareamiento, mientras que la amputación de antenas a los machos lo reduce totalmente. La presencia de feromona sintética en el ambiente reduce significativamente el acoplamiento, siendo esta reducción mayor cuanto mayor es la dosis de feromona. En estos experimentos también se demuestra que cuanto mayor es la densidad de población menor es la reducción del acoplamiento. Finalmente, se ha observado que no hay diferencias de apareamiento con o sin plantas.

Base temperature and simulation model for nodes appearance in cape gooseberry (Physalis peruviana L.)

Data was analyzed on development of the solanaceen fruit crop Cape gooseberry to evaluate how well a classical thermal time model could describe node appearance in different environments. The data used in the analysis were obtained from experiments conducted in Colombia in open fields and greenhouse condition at two locations with different climate. An empirical, non linear segmented model was used to estimate the base temperature and to parameterize the model for simulation of node appearance vs. time. The base temperature (Tb) used to calculate the thermal time (TT, ºCd) for node appearance was estimated to be 6.29 ºC. The slope of the first linear segment was 0.023 nodes per TT and 0.008 for the second linear segment. The time at which the slope of node apperance changed was 1039.5 ºCd after transplanting, determined from a statistical analysis of model for the first segment. When these coefficients were used to predict node appearance at all locations, the model successfully fit the observed data (RSME=2.1), especially for the first segment where node appearance was more homogeneous than the second segment. More nodes were produced by plants grown under greenhouse conditions and minimum and maximum rates of node appearance rates were also higher.

Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.

BACKGROUND: The past three decades have seen rapid improvements in the diagnosis and treatment of most cancers and the most important contributor has been research. Progress in rare cancers has been slower, not least because of the challenges of undertaking research. SETTINGS: The International Rare Cancers Initiative (IRCI) is a partnership which aims to stimulate and facilitate the development of international clinical trials for patients with rare cancers. It is focused on interventional--usually randomized--clinical trials with the clear goal of improving outcomes for patients. The key challenges are organisational and methodological. A multi-disciplinary workshop to review the methods used in ICRI portfolio trials was held in Amsterdam in September 2013. Other as-yet unrealised methods were also discussed. RESULTS: The IRCI trials are each presented to exemplify possible approaches to designing credible trials in rare cancers. Researchers may consider these for use in future trials and understand the choices made for each design. INTERPRETATION: Trials can be designed using a wide array of possibilities. There is no 'one size fits all' solution. In order to make progress in the rare diseases, decisions to change practice will have to be based on less direct evidence from clinical trials than in more common diseases.

Optimal capital structure: a trade-off model and its empirical testing

In the present research we have set forth a new, simple, Trade-Off model that would allow us to calculate how much debt and, by default, how much equity a company should have, using easily available information and calculating the cost of debt dynamically on the basis of the effect that the capital structure of the company has on the risk of bankruptcy; in an attempt to answer this question. The proposed model has been applied to the companies that make up the Dow Jones Industrial Average (DJIA) in 2007. We have used consolidated financial data from 1996 to 2006, published by Bloomberg. We have used simplex optimization method to find the debt level that maximizes firm value. Then, we compare the estimated debt with real debt of companies using statistical nonparametric Mann-Whitney. The results indicate that 63% of companies do not show a statistically significant difference between the real and the estimated debt.

Cell-Cell interaction in erythropoiesis: role of human monocytes

Erythroid burst forming units (BFU-E) are proliferative cells present in peripheral blood and bone marrow which may be precursors of the erythroid colony forming cell found in the bone marrow. To examine the possible role of monocyte-macrophages in the modulation of erythropoiesis, the effect of monocytes on peripheral blood BFU-E proliferation in response to erythropoietin was investigated in the plasma clot culture system. Peripheral blood mononuclear cells from normal human donors were separated into four fractions. Fraction-I cells were obtained from the interface of Ficoll-Hypaque gradients (20-30% monocytes; 60-80% lymphocytes); fraction-II cells were fraction-I cells that were nonadherent to plastic (2-10% monocytes; 90-98% lymphocytes); fraction-III cells were obtained by incubation of fraction-II cells with carbonyl iron followed by Ficoll-Hypaque centrifugation (>99% lymphocytes); and fraction-IV cells represented the adherent population of fraction-II cells released from the plastic by lidocaine (>95% monocytes). When cells from these fractions were cultured in the presence of erythropoietin, the number of BFU-E-derived colonies was inversely proportional to the number of monocytes present (r = ¿0.96, P < 0.001). The suppressive effect of monocytes on BFU-E proliferation was confirmed by admixing autologous purified monocytes (fraction-IV cells) with fraction-III cells. Monocyte concentrations of ¿20% completely suppressed BFU-E activity. Reduction in the number of plated BFU-E by monocyte dilution could not account for these findings: a 15% reduction in the number of fraction-III cells plated resulted in only a 15% reduction in colony formation. These results indicate that monocyte-macrophages may play a significant role in the regulation of erythropoiesis and be involved in the pathogenesis of the hypoproliferative anemias associated with infection and certain neoplasia in which increased monocyte activity and monopoiesis also occur.

Programa de Càlcul Nutricional Professional (PCN Pro)

Aplicació de càlcul nutricional que permet les següents funcionalitats: Gestió d’Individus/Pacients permet organitzar els pacients en carpetes i subcarpetes, podent incorporar un històric de dades antropomètriques i dietètic i calcular els següents dades: IMC (Índex de Massa Corporal), Índex Cintura / Maluc, Estima el pes ideal orientatiu, Estimació de Despesa Energètica per: Harris-Benedict, FAO-OMS, Mifflin-St. Jeor. En base a la informació introduïda a la pestanya Activitat Física estima també la despesa energètica tenint en compte l’activitat física realitzada per l’individu (permet estimar la despesa energètica per 605 activitats).Estimació de necessitats energètiques en malalts per Long et al. i Ireton-Jones amb la base del càlcul del Metabolisme Basal de Harris-Benedict. Introduint els plecs (Plec Pectoral, Plec Bíceps, Plec Abdominal, Plec Supraespinal, Plec Cuixa anterior, Plec Cama medial, Plec Subescapular, Plec Tricipital), els diàmetres (Diàmetre Antero-Posterior Tòrax, Diàmetre Sagital, Diàmetre Húmer, Diàmetre Fèmur, Diàmetre Biacromial, Diàmetre Transversal Tòrax, Diàmetre Biileocrestal) i els perímetres (Perímetre Braç flexionat, Perímetre Braç, Perímetre Canell, Perímetre Cuixa, Perímetre Cama, Perímetre Tòrax) el programa és capaç de calcular el % de greix, massa òssia, massa muscular i massa residual per diferents fórmules (% Gas Yuhasz, % Gras Faulkner, % Gras Siri, % Gras Brozek, Distribució corporal de Drinkwater). També calcula el perímetre muscular del braç i la cama. També calcula el Pes Objectiu en relació a un % Greix objectiu, calculant quin pes hauria de tenir el pacient per un % de Greix donat.

Electrical signature of modern and ancient tectonic processes in the crust of the Atlas mountains of Morocco.

The Atlas Mountains in Morocco are considered as type examples of intracontinental chains, with high topography that contrasts with moderate crustal shortening and thickening. Whereas recent geological studies and geodynamic modeling have suggested the existence of dynamic topography to explain this apparent contradiction, there is a lack of modern geophysical data at the crustal scale to corroborate this hypothesis. Newly-acquired magnetotelluric data image the electrical resistivity distribution of the crust from the Middle Atlas to the Anti-Atlas, crossing the tabular Moulouya Plain and the High Atlas. All the units show different and unique electrical signatures throughout the crust reflecting the tectonic history of development of each one. In the upper crust electrical resistivity values may be associated to sediment sequences in the Moulouya and Anti-Atlas and to crustal scale fault systems in the High Atlas developed during the Cenozoic times. In the lower crust the low resistivity anomaly found below the Mouluya plain, together with other geophysical (low velocity anomaly, lack of earthquakes and minimum Bouguer anomaly) and geochemical (Neogene-Quaternary intraplate alkaline volcanic fields) evidence, infer the existence of a small degree of partial melt at the base of the lower crust. The low resistivity anomaly found below the Anti-Atlas may be associated with a relict subduction of Precambrian oceanic sediments, or to precipitated minerals during the release of fluids from the mantle during the accretion of the Anti-Atlas to the West African Supercontinent during the Panafrican orogeny ca. 685 Ma).

Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease

Background: The long-term efficacy and safety of aclidinium bromide, a novel, long-acting muscarinic antagonist, were investigated in patients with moderate to severe chronic obstructive pulmonary disease (COPD). Methods: In two double-blind, 52-week studies, ACCLAIM/COPD I (n = 843) and II (n = 804), patients were randomised to inhaled aclidinium 200 μg or placebo once-daily. Patients were required to have a postbronchodilator forced expiratory volume in 1 second (FEV1)/forced vital capacity ratio of ≤70% and FEV1 <80% of the predicted value. The primary endpoint was trough FEV1 at 12 and 28 weeks. Secondary endpoints were health status measured by St George"s Respiratory Questionnaire (SGRQ) and time to first moderate or severe COPD exacerbation. Results: At 12 and 28 weeks, aclidinium improved trough FEV1 versus placebo in ACCLAIM/COPD I (by 61 and 67 mL; both p < 0.001) and ACCLAIM/COPD II (by 63 and 59 mL; both p < 0.001). More patients had a SGRQ improvement ≥4 units at 52 weeks with aclidinium versus placebo in ACCLAIM/COPD I (48.1% versus 39.5%; p = 0.025) and ACCLAIM/COPD II (39.0% versus 32.8%; p = 0.074). The time to first exacerbation was significantly delayed by aclidinium in ACCLAIM/COPD II (hazard ratio [HR] 0.7; 95% confidence interval [CI] 0.55 to 0.92; p = 0.01), but not ACCLAIM/COPD I (HR 1.0; 95% CI 0.72 to 1.33; p = 0.9). Adverse events were minor in both studies. Conclusion: Aclidinium is effective and well tolerated in patients with moderate to severe COPD. Trial registration: ClinicalTrials.gov: NCT00363896 ACCLAIM/COPD I) and NCT00358436 (ACCLAIM/COPD II).

Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial.

BACKGROUND: The recent large randomized controlled trial of glutamine and antioxidant supplementation suggested that high-dose glutamine is associated with increased mortality in critically ill patients with multiorgan failure. The objectives of the present analyses were to reevaluate the effect of supplementation after controlling for baseline covariates and to identify potentially important subgroup effects. MATERIALS AND METHODS: This study was a post hoc analysis of a prospective factorial 2 × 2 randomized trial conducted in 40 intensive care units in North America and Europe. In total, 1223 mechanically ventilated adult patients with multiorgan failure were randomized to receive glutamine, antioxidants, both glutamine and antioxidants, or placebo administered separate from artificial nutrition. We compared each of the 3 active treatment arms (glutamine alone, antioxidants alone, and glutamine + antioxidants) with placebo on 28-day mortality. Post hoc, treatment effects were examined within subgroups defined by baseline patient characteristics. Logistic regression was used to estimate treatment effects within subgroups after adjustment for baseline covariates and to identify treatment-by-subgroup interactions (effect modification). RESULTS: The 28-day mortality rates in the placebo, glutamine, antioxidant, and combination arms were 25%, 32%, 29%, and 33%, respectively. After adjusting for prespecified baseline covariates, the adjusted odds ratio of 28-day mortality vs placebo was 1.5 (95% confidence interval, 1.0-2.1, P = .05), 1.2 (0.8-1.8, P = .40), and 1.4 (0.9-2.0, P = .09) for glutamine, antioxidant, and glutamine plus antioxidant arms, respectively. In the post hoc subgroup analysis, both glutamine and antioxidants appeared most harmful in patients with baseline renal dysfunction. No subgroups suggested reduced mortality with supplements. CONCLUSIONS: After adjustment for baseline covariates, early provision of high-dose glutamine administered separately from artificial nutrition was not beneficial and may be associated with increased mortality in critically ill patients with multiorgan failure. For both glutamine and antioxidants, the greatest potential for harm was observed in patients with multiorgan failure that included renal dysfunction upon study enrollment.

DENSIDADE DE PLANTIO E PRODUÇÃO DO MARACUJAZEIRO-AZEDO NO SUL DO BRASIL

RESUMO Objetivou-se avaliar a produção e a qualidade dos frutos do maracujazeiro-azedo em relação a diferentes densidades de plantio na região de Pelotas/Rio Grande do Sul/Brasil. O experimento foi conduzido no ciclo de 2011/2012, apenas com plantas de um ano, e no ciclo de 2012/2013, avaliaram-se plantas de um e dois anos. Os tratamentos foram estabelecidos de acordo com as seguintes densidades (plantas ha-1): 1.600 (D1); 2.666; 3.200 (D3). No ciclo de 2012/2013, as plantas de dois anos do tratamento D3 foram desbastadas, permanecendo-se com 1.600 plantas ha-1. O tratamento mais adensado, com 3.200 plantas ha-1 e plantas de um ano, apresentou melhor desempenho produtivo, independentemente do ciclo avaliado. As plantas de dois anos (ciclo de 2012/2013) não demonstraram diferença quanto à produtividade e número de frutos por hectare nas densidades avaliadas. A qualidade dos frutos não foi influenciada pelas densidades de plantio em nenhum ciclo avaliado.

Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data.

BACKGROUND: Artemisinin-resistant Plasmodium falciparum has emerged in the Greater Mekong sub-region and poses a major global public health threat. Slow parasite clearance is a key clinical manifestation of reduced susceptibility to artemisinin. This study was designed to establish the baseline values for clearance in patients from Sub-Saharan African countries with uncomplicated malaria treated with artemisinin-based combination therapies (ACTs). METHODS: A literature review in PubMed was conducted in March 2013 to identify all prospective clinical trials (uncontrolled trials, controlled trials and randomized controlled trials), including ACTs conducted in Sub-Saharan Africa, between 1960 and 2012. Individual patient data from these studies were shared with the WorldWide Antimalarial Resistance Network (WWARN) and pooled using an a priori statistical analytical plan. Factors affecting early parasitological response were investigated using logistic regression with study sites fitted as a random effect. The risk of bias in included studies was evaluated based on study design, methodology and missing data. RESULTS: In total, 29,493 patients from 84 clinical trials were included in the analysis, treated with artemether-lumefantrine (n = 13,664), artesunate-amodiaquine (n = 11,337) and dihydroartemisinin-piperaquine (n = 4,492). The overall parasite clearance rate was rapid. The parasite positivity rate (PPR) decreased from 59.7 % (95 % CI: 54.5-64.9) on day 1 to 6.7 % (95 % CI: 4.8-8.7) on day 2 and 0.9 % (95 % CI: 0.5-1.2) on day 3. The 95th percentile of observed day 3 PPR was 5.3 %. Independent risk factors predictive of day 3 positivity were: high baseline parasitaemia (adjusted odds ratio (AOR) = 1.16 (95 % CI: 1.08-1.25); per 2-fold increase in parasite density, P <0.001); fever (>37.5 °C) (AOR = 1.50 (95 % CI: 1.06-2.13), P = 0.022); severe anaemia (AOR = 2.04 (95 % CI: 1.21-3.44), P = 0.008); areas of low/moderate transmission setting (AOR = 2.71 (95 % CI: 1.38-5.36), P = 0.004); and treatment with the loose formulation of artesunate-amodiaquine (AOR = 2.27 (95 % CI: 1.14-4.51), P = 0.020, compared to dihydroartemisinin-piperaquine). CONCLUSIONS: The three ACTs assessed in this analysis continue to achieve rapid early parasitological clearance across the sites assessed in Sub-Saharan Africa. A threshold of 5 % day 3 parasite positivity from a minimum sample size of 50 patients provides a more sensitive benchmark in Sub-Saharan Africa compared to the current recommended threshold of 10 % to trigger further investigation of artemisinin susceptibility.